SAN DIEGO – April 17, 2013 — OncoSec Medical Inc. (OTCQB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers, announced that Punit Dhillon, President and CEO, will present a company overview at the 2013 BIO International Convention. Mr. Dhillon’s presentation will take place on Wednesday, April 24, 2013 at 9:00 a.m. CT at the McCormick Place convention center in Chicago, IL.
About Bio International Convention 2013
Bio International Convention is the global event for the biotechnology industry attracting over 16,000 decision makers from 65 countries. The three-day event attracts thousands of companies from around the world and helps build strategic partnerships. BIO covers the wide spectrum of life science innovations and application areas. Drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy are just a few of the industries represented at the BIO International Convention.